Pacira BioSciences Inc PCRX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Pacira BioSciences Announces Stockholders Have Elected All Three of the Company's Director Nominees at Annual Meeting
-
Pacira BioSciences Reminds Stockholders to Vote the BLUE Proxy Card "FOR" the Election of the Company's Highly Qualified Nominees Ahead of its Annual Meeting
-
Pacira BioSciences Highlights Leading Independent Proxy Advisory Firm ISS' Recommendation to Vote "FOR" All of Pacira's Director Nominees
-
DOMA PERPETUAL CAPITAL MANAGEMENT QUESTIONS WHY SHAREHOLDERS SHOULD VOTE TO CONTINUE WITH A BOARD THAT HAS OVERSEEN A DECADE OF VALUE DESTRUCTION
-
A LETTER TO PACIRA BIOSCIENCES SHAREHOLDERS FROM DOMA PERPETUAL CAPITAL MANAGEMENT LLC
-
DOMA Perpetual Director Nominees Send Letter to Shareholders of Pacira Biosciences
-
DOMA Perpetual Issues & Mails Letter to Shareholders of Pacira BioSciences - Along with its Definitive Proxy Statement & WHITE Proxy Card - Urging Shareholders to Vote "FOR" DOMA's Three Highly Qualified, Independent Board Candidates
Trading Information
- Previous Close Price
- $25.48
- Day Range
- $25.26–25.89
- 52-Week Range
- $18.80–27.64
- Bid/Ask
- $10.34 / $40.86
- Shares Outstanding
- 39.35M
- Market Cap
- $1.00B
- Volume/Avg
- 280 / 517,943
Key Statistics
- Price/Earnings (Normalized)
- 9.78
- Price/Sales
- 1.52
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 14.76%
Company Profile
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 829
- Website
- https://www.pacira.com
Valuation
|
Metric
|
PCRX
|
|---|---|
Price/Earnings (Normalized) | 9.78 |
Price/Book Value | 1.54 |
Price/Sales | 1.52 |
Price/Cash Flow | 5.77 |
Price/Earnings
PCRX
Financial Strength
|
Metric
|
PCRX
|
|---|---|
Quick Ratio | 3.01 |
Current Ratio | 4.73 |
Interest Coverage | 0.67 |
Quick Ratio
PCRX
Profitability
|
Metric
|
PCRX
|
|---|---|
Return on Assets (Normalized) | 8.47% |
Return on Equity (Normalized) | 16.08% |
Return on Invested Capital (Normalized) | 9.25% |
Return on Assets
PCRX
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|JFSPW^F | LOCK|#?#p# | $69B | |||
| Haleon PLC ADR
HLN
| LOCK|%C<T?&r | LOCK|@^S | $43B | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| LOCK|!&!K<<& | LOCK|k!Qv | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|%?^<&&< | LOCK|$d | $32B | |||
| Viatris Inc
VTRS
| LOCK|cs^KxV | LOCK|mJR | $19B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|%Gr | LOCK|#% | $13B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|?$B<$TM | LOCK|Mcd | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|$^j<$B | LOCK|N>d | $8B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|lb#@HF | LOCK|>sqn% | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|LV>hj! | LOCK|ZT | $1B |
United States